Intellipharmaceutics International Inc. Quarterly Deferred Tax Assets, Valuation Allowance in CAD from Q4 2014 to Q4 2018

Taxonomy & unit
us-gaap: CAD and USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Intellipharmaceutics International Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2014 to Q4 2018.
  • Intellipharmaceutics International Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending November 30, 2018 was CA$25.2M, a 23.9% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (CAD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2018 25.2M +4.86M +23.9% Nov 30, 2018 20-F/A 2019-03-04
Q4 2017 20.3M +3.36M +19.8% Nov 30, 2017 20-F/A 2019-03-04
Q4 2016 17M +2.68M +18.8% Nov 30, 2016 20-F/A 2019-03-04
Q4 2015 14.3M +1.8M +14.5% Nov 30, 2015 20-F 2018-03-01
Q4 2014 12.5M Nov 30, 2014 20-F 2017-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.